Efficacy of an Intranasal Tear Neurostimulator in Sjögren Syndrome Patients
Jonathan Lilley,1 Erin C O’Neil,1 Vatinee Y Bunya,1 Kennedy Johnson,1 Gui-Shuang Ying,2 Peiying Hua,2 Mina Massaro-Giordano1 1Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; 2Center for Preventive Ophthalmology...
Guardado en:
Autores principales: | Lilley J, O'Neil EC, Bunya VY, Johnson K, Ying GS, Hua P, Massaro-Giordano M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ff73b5beb744ad7a96df2afa155d087 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stimulating Tear Production: Spotlight on Neurostimulation
por: Yu MD, et al.
Publicado: (2021) -
Infections as Risk Factor of Sjögren’s Syndrome
por: Utomo SW, et al.
Publicado: (2020) -
Sjögren's syndrome and systemic lupus erythematosus: links and risks
por: Pasoto SG, et al.
Publicado: (2019) -
A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease
por: Friedman NJ, et al.
Publicado: (2016) -
Review of autoantigens in Sjögren’s syndrome: an update
por: Tong L, et al.
Publicado: (2017)